New Launches

NexChange’s Healthtech O2O summit in Hong Kong

The Healthtech O2O Summit will be held on February 1, 2018. Nearly 1,000 delegates will come to the Hong Kong Convention and Exhibition Centre for a conference featuring advances in health technology and how major medical players are adopting these technologies.

“Hong Kong has the ideal mix of health, technology and medical entrepreneurs and investors to attract world players,” said NexChange CEO Juwan Lee. “Keynote speakers, in-depth panels and pitching entrepreneurs make this event a must-attend on the global healthtech calendar.” NexChange provides an innovation ecosystem as a service, specializing in fintech, insurtech, blockchain, AI and healthtech.

Technology is brought to bear on healthcare management through exciting blockchain applications that will dramatically improve privacy and accuracy. The insurance industry is actively investing in healthtech to improve health outcomes, combining it with other insurtech advances like AI, big data and more.

Medical advances are happening in Hong Kong and world leading scientists like McGill University’s Dr Moshe Szyf, James McGill Professor and GlaxoSmithKline-CIHR Chair in Pharmacology, will speak about the work happening with his Hong Kong firm HKG epitherapeutics.

“The Personalisation of Medicine” and “Facing Ageing with Technology” are major focuses at the event. Hong Kong is the longest-lived territory in the world and an ideal place for medical research and market testing. From personalized gene therapies to combating cancer to lifestyle drivers to promote healthier populations with AI and mobile technology, Healthtech O2O is delivering cutting edge speakers and companies.

“Healthtech O2O is poised to become the centre of Asia’s healthtech ecosystem, starting in Hong Kong and spreading across the region,” said Mr Lee. “We are honoured and excited to be invited to participate by InvestHK, our partners in this venture.”

Speaker List

1. Dato’ Chevy Beh, CEO, BookDoc

2. Michael Bruck – Partner, SPARQ Capital

3. Al Chalabi – Director, CASP-R; and Author, “Juvenescence: Investing in the Age of Longevity”

4. Dr. Allen Chan, Co-founder, Cirina (Grail)

5. Scarlett Chen, Director of Strategic Investments, Prudential

6. Bonnie Cheung, Venture Partner, 500 Startups

7. Dr. Ngai-tseung Cheung, Chief Medical Informatics Officer, Hong Kong Hospital Authority

8. Dr. Ken Chu, Programmes Director, Biorna Quantics

9. Dr. Tak-yi Chui, Undersecretary for Food and Health, the Government of Hong Kong S.A.R.

10. Peter Ohnemus, CEO, dacadoo

11. Ildar Fazulyanov, Founder & CEO, WELL Network

12. Christopher Fisher, Managing Partner, Click Ventures

13. Darryl G. Glover, Principal and Chief Clinical Officer, iSolve

14. Dr. Justin Gregory, Founder & CEO, Biorna Quantics

15. Dr. Hanif Kanji, CEO, Sinophi Healthcare

16. Xin Yun Khor, CEO, LeadinHealth

17. Michelle Y Lai, Investor and Healthtech Consultant

18. Juwan Lee, Founder & CEO, NexChange

19. Samson Lee, Co-founder, Hong Kong Blockchain Centre

20. Dr. Hung-wing Li, Associate Professor, Department of Chemistry, Hong Kong Baptist University

21. Richard Ljuhar, Founder & CEO, ImageBiopsy Lab

22. Karin Munasinghe, Senior VP, APAC Marketing, Fresenius Medical Care

23. Dr. Youjin Na, CEO, Proteina

24. Vijay Reddy, Founder, Nubis Health

25. Rob Royea, CEO, Cyrcadia Asia Ltd.

26. Dr. Moshe Szyf, CEO, HKG Epitherapeutics Limited

27. Dr. Wei-tek Tsai, Co-founder, Hong Kong Blockchain Centre

28. Raymond Wong, Head of Investment, HKSTP

29. Seung-hee Yang, Chief Communications Officer, Proteina

30. Henry Yau, Managing Director, The University of Hong Kong Clinical Trials Centre (HKU-CTC)

31. Richard Ordman, Vice President of Global Marketing, Medix Group

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top